PA
IGC icon

Parallel Advisors’s IGC Pharma IGC Stock Holding History

Parallel Advisors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,655
Closed -$11K – 2186
2018
Q3 		$11K Buy
+1,655
New +$1.72K ﹤0.01% 1403

Other funds holding IGC

CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Parallel Advisors's IGC Position: Q4 2018 in Review

Parallel Advisors sold out of IGC Pharma (IGC) in Q4 2018, closing a stake of 1,655 shares — an estimated $11K sold.

Parallel Advisors first reported a position in IGC in Q3 2018 and held it in 1 quarter. The position peaked at $11K in Q3 2018. 4 funds tracked by Wall St. Rank hold IGC as of Q4 2018.

  • Parallel Advisors reported no remaining IGC Pharma position as of Q4 2018 after selling out during the quarter.
  • Parallel Advisors sold 1,655 IGC Pharma shares in Q4 2018, an estimated $11K.
  • Parallel Advisors first reported a position in IGC Pharma in Q3 2018 and held it in 1 quarter.
  • Parallel Advisors's IGC Pharma position peaked at $11K in Q3 2018.
  • 4 funds tracked by Wall St. Rank held IGC Pharma as of Q4 2018.

Based on Parallel Advisors's 13F filing for Q4 2018, filed 5 Feb 2019.